Answers are grounded in this paper and cite their sources.
Acute lung injury (ALI) is a serious clinical condition with high morbidity and mortality rates. Current ALI treatments have limitations. Natural products from traditional Chinese medicine (TCM) exhibit multi-component, multi-target and multi-pathway regulatory properties with good safety, making them promising candidates for ALI treatment. This review systematically summarizes the activation pathways of pyroptosis, its molecular regulatory network in ALI and the mechanisms by which natural products regulate pyroptosis to inhibit ALI progression. A 'natural products-pyroptosis-ALI' axis conceptual framework is proposed to provide theoretical support for clinical translation. Systematic literature searches were conducted on CNKI, Web of Science and PubMed up to March 2026, using keywords related to natural products, ALI and pyroptosis. This review covers TCM herbs, natural small-molecule compounds and TCM formulas that modulate pyroptosis to alleviate ALI, with all animal experiments adhering to ethical and international standards. Various natural products and TCM formulae effectively target pyroptosis, inhibiting NLRP3 inflammasome assembly, Caspase-1 activation and Gasdermin D pore formation, thereby reducing IL-1β/IL-18 release, alleviating inflammatory cascades, protecting alveolar-capillary barrier integrity and mitigating oxidative stress. Activated pyroptosis further disturbs mitophagy, triggers endoplasmic reticulum stress, engages the gut-lung axis, modulates epigenetic reprogramming and promotes epithelial-mesenchymal transition to amplify ALI. This review fills gaps in the systematic characterization of pyroptosis-ALI relationships and natural product-based therapies, aiming to expand ALI treatment options and advance ALI therapeutic development.
No takes yet. Share an insight, caveat, or question.
Luo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: